The Cigna Group (CI)
- Previous Close
308.86 - Open
309.40 - Bid 302.53 x 1000
- Ask 321.00 x 800
- Day's Range
307.78 - 320.95 - 52 Week Range
262.03 - 370.83 - Volume
2,055,825 - Avg. Volume
1,867,190 - Market Cap (intraday)
85.737B - Beta (5Y Monthly) 0.48
- PE Ratio (TTM)
17.89 - EPS (TTM)
17.94 - Earnings Date Jul 30, 2025 - Aug 4, 2025
- Forward Dividend & Yield 6.04 (1.88%)
- Ex-Dividend Date Jun 3, 2025
- 1y Target Est
375.13
The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers. The company's Cigna Healthcare segment offers medical, pharmacy, behavioral health, dental, and other products and services for insured and self-insured customers; Medicare Advantage, Medicare Supplement, and Medicare Part D plans for seniors, as well as individual health insurance plans; and health care coverage in its international markets, as well as health care benefits for mobile individuals and employees of multinational organizations. In addition, it offers permanent insurance contracts sold to corporations to provide coverage on the lives of certain employees for financing employer-paid future benefit obligations and stop loss insurance. The company distributes its products and services through insurance brokers and consultants; directly to employers, unions and other groups, or individuals; and private and public exchanges. The company was formerly known as Cigna Corporation and changed its name to The Cigna Group in February 2023. The company was founded in 1792 and is headquartered in Bloomfield, Connecticut.
www.cigna.comRecent News: CI
View More
Performance Overview: CI
Trailing total returns as of 5/16/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: CI
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: CI
View MoreValuation Measures
Market Cap
85.74B
Enterprise Value
107.85B
Trailing P/E
17.89
Forward P/E
10.93
PEG Ratio (5yr expected)
0.62
Price/Sales (ttm)
0.35
Price/Book (mrq)
2.13
Enterprise Value/Revenue
0.42
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
1.97%
Return on Assets (ttm)
4.03%
Return on Equity (ttm)
13.21%
Revenue (ttm)
255.37B
Net Income Avi to Common (ttm)
5.03B
Diluted EPS (ttm)
17.94
Balance Sheet and Cash Flow
Total Cash (mrq)
9.06B
Total Debt/Equity (mrq)
75.34%
Levered Free Cash Flow (ttm)
7.58B
Research Analysis: CI
View MoreResearch Reports: CI
View MoreLowering target price to $332.00
THE CIGNA GROUP has an Investment Rating of BUY; a target price of $332.000000; an Industry Subrating of High; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of High; a Growth Subrating of Medium; and a Value Subrating of High.
RatingPrice TargetHealthcare Services: Medicaid and PBMs Still Under Fire in Updated Regulatory Moves
Cigna primarily provides pharmacy benefit management and health insurance services. Its PBM and specialty pharmacy services, which were greatly expanded by its 2018 merger with Express Scripts, are mostly sold to health insurance plans and employers. Its largest PBM contract is with the Department of Defense (current contract through 2029), and it recently won a multiyear deal with top-tier insurer Centene. In health insurance and other benefits, Cigna primarily serves employers through self-funding arrangements, and the company operates mostly in the US with 17 million US and 2 million international medical members covered as of December 2024.
RatingPrice TargetHealthcare Services: Medicaid and PBMs Still Under Fire in Updated Regulatory Moves
Cigna primarily provides pharmacy benefit management and health insurance services. Its PBM and specialty pharmacy services, which were greatly expanded by its 2018 merger with Express Scripts, are mostly sold to health insurance plans and employers. Its largest PBM contract is with the Department of Defense (current contract through 2029), and it recently won a multiyear deal with top-tier insurer Centene. In health insurance and other benefits, Cigna primarily serves employers through self-funding arrangements, and the company operates mostly in the US with 17 million US and 2 million international medical members covered as of December 2024.
RatingPrice TargetLowering target price to $367.00
THE CIGNA GROUP has an Investment Rating of BUY; a target price of $367.000000; an Industry Subrating of High; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of High.
RatingPrice Target